Journal article icon

Journal article

Mpox (monkeypox) risk and mortality associated with HIV infection: a national case–control study in Nigeria

Abstract:
INTRODUCTION: Recent outbreaks of mpox are characterised by changes in the natural history of the disease, the demographic and clinical characteristics of the cases, and widening geographical distribution. We investigated the role of HIV and other sexually transmitted infections (STIs) coinfection among cases in the re-emergence of mpox to inform national and global response. METHODS: We conducted a national descriptive and case-control study on cases in the 2017-2019 Nigerian mpox outbreak. Mpox cases were age, sex and geographical area matched each with two randomly selected controls from a representative national HIV/AIDS survey. Logistic regression was used to investigate the association between HIV infection and the risk of mpox acquisition and death. RESULTS: Among 204 suspected mpox cases, 86 were confirmed (median age 31 years (IQR 27-38 years), mostly males (61 cases, 70.9%). Three-fifths of mpox cases had serological evidence of one or more STIs with 27.9% (24/86) coinfected with HIV. The case fatality rate was 9.4% (8/86) and 20.8% (5/24) overall and in HIV positive cases respectively. Mpox cases were more likely to have HIV coinfection compared with an age, gender and geography-matched control group drawn from the general population (OR 45 (95% CI 6.1 to 333.5, p=0.002) and when compared with non mpox rash cases (7.29 (95% CI 2.6 to 20.5, p<0.0001)). HIV coinfection and young age were associated with mortality among mpox cases (aOR 13.66 (95% CI 1.88 to 98.95, p=0.010) and aOR 0.90 (0.82-0.97, p=0.008), respectively). CONCLUSION: HIV infection was associated with a higher risk of contracting and dying from mpox. Children are also at high risk of death. STIs in mpox cases may be suggestive of high-risk sexual behaviours among these individuals.
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Files:
Publisher copy:
10.1136/bmjgh-2023-013126

Authors

More by this author
Role:
Author
ORCID:
0000-0003-0900-4772
More by this author
Role:
Author
ORCID:
0000-0003-0229-9838
More by this author
Role:
Author
ORCID:
0000-0002-1837-6255
More by this author
Role:
Author
ORCID:
0000-0002-7879-634X


Publisher:
BMJ Publishing Group
Journal:
BMJ Global Health More from this journal
Volume:
8
Issue:
11
Pages:
e013126-e013126
Publication date:
2023-11-30
Acceptance date:
2023-10-21
DOI:
EISSN:
2059-7908
ISSN:
2059-7908


Language:
English
Keywords:
Pubs id:
1577861
Local pid:
pubs:1577861
Source identifiers:
W4389245012
Deposit date:
2026-06-04
ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP